proline and goralatide

proline has been researched along with goralatide in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Carretero, OA; Cavasin, MA; Rhaleb, NE; Yang, XP	1
García-Horsman, JA; Jokinen, B; Männistö, PT; Moreno-Baylach, MJ; Myöhänen, TT; Tenorio-Laranga, J; Vázquez-Sánchez, R	1
Deng, HJ; Gong, HB; Gong, RB; Miao, ZY; Tang, XY; Zhang, CM	1

Reviews

1 review(s) available for proline and goralatide

Article	Year
[Meta-analysis of Ac-SDKP inhibition of Pulmonary fibrosis in animal models]. Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases, 2023, Apr-20, Volume: 41, Issue:4 Topics: Animals; Disease Models, Animal; Fibrosis; Proline; Pulmonary Fibrosis; Rats; Rats, Wistar	2023

Other Studies

2 other study(ies) available for proline and goralatide

Article	Year
Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:5 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dipeptides; Indoles; Kidney; Kidney Cortex; Male; Myocardium; Nitriles; Oligopeptides; Organ Specificity; Proline; Prolyl Oligopeptidases; Protease Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Serine Endopeptidases; Thiazoles; Thiazolidines; Thymosin	2004
Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner. British journal of pharmacology, 2011, Volume: 163, Issue:8 Topics: Angiogenesis Inhibitors; Animals; Biocompatible Materials; Collagen; Drug Combinations; Endothelial Cells; Growth Inhibitors; Humans; Kidney; Laminin; Male; Neovascularization, Pathologic; Oligopeptides; Proline; Prolyl Oligopeptidases; Proteoglycans; Rats; Rats, Inbred WF; Serine Endopeptidases; Serine Proteinase Inhibitors; Thymosin; Umbilical Veins	2011

Article

Year

Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP.

Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:5

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dipeptides; Indoles; Kidney; Kidney Cortex; Male; Myocardium; Nitriles; Oligopeptides; Organ Specificity; Proline; Prolyl Oligopeptidases; Protease Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Serine Endopeptidases; Thiazoles; Thiazolidines; Thymosin

2004

Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner.

British journal of pharmacology, 2011, Volume: 163, Issue:8

Topics: Angiogenesis Inhibitors; Animals; Biocompatible Materials; Collagen; Drug Combinations; Endothelial Cells; Growth Inhibitors; Humans; Kidney; Laminin; Male; Neovascularization, Pathologic; Oligopeptides; Proline; Prolyl Oligopeptidases; Proteoglycans; Rats; Rats, Inbred WF; Serine Endopeptidases; Serine Proteinase Inhibitors; Thymosin; Umbilical Veins

2011